Off-the-shelf immune drug shows promise in aggressive multiple myeloma

Source: Multiple Myeloma News — ScienceDaily

A subcutaneous injection of the immune-boosting drug teclistamab was found to be safe and elicit responses in a majority of patients with relapsed or refractory multiple myeloma.
Read More